1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
fax: (765) 494-0781
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Viral Hepatitis
You have full text access to this OnlineOpen article
Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression†
Article first published online: 8 MAY 2009
DOI: 10.1002/hep.22996
Copyright © 2009 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Studach, L. L., Rakotomalala, L., Wang, W.-H., Hullinger, R. L., Cairo, S., Buendia, M.-A. and Andrisani, O. M. (2009), Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression. Hepatology, 50: 414–423. doi: 10.1002/hep.22996
- †
Potential conflict of interest: Nothing to report.
- ‡
fax: (765) 494-0781
Publication History
- Issue published online: 29 JUL 2009
- Article first published online: 8 MAY 2009
- Accepted manuscript online: 8 MAY 2009 12:00AM EST
- Manuscript Accepted: 18 MAR 2009
- Manuscript Received: 9 OCT 2008
Funded by
- National Institutes of Health. Grant Number: NIDDK 044533
- Purdue University Bilsland graduate student fellowship
- National Science Foundation graduate student fellowship
References
- 1, , , . Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129–1133.
- 2. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000; 10: 185–200.
- 3, , , , , , et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864–870.
- 4, , , , , , et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434: 907–913.
- 5, , . An oncogene-induced DNA damage model for cancer development. Science 2008; 319: 1352–1355.
- 6, , , , , , et al. Defective DNA strand break repair causes chromosomal instability and accelerated liver carcinogenesis in mice. HEPATOLOGY 2008; 47: 2079–2088.
- 7, , , , . Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci U S A 2000; 97: 3236–3241.
- 8, , , , , , et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci U S A 1994; 91: 12808–12812.
- 9, . The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int J Oncol 1999; 15: 373–379.
- 10, , , , . Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein. HEPATOLOGY 2002; 36: 1401–1407.
- 11, , , , , . Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. HEPATOLOGY 1998; 27: 1109–1120.
- 12, , . Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994; 68: 2026–2030.
- 13, , , , , , et al. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997; 14: 395–404.
- 14, , . Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol 2001; 75: 3851–3858.
- 15, . The enigmatic X gene of hepatitis B virus. J Virol 2004; 78: 12725–12734.
- 16, , , , , . Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus non-transforming hepatocyte (AML12) cell lines. J Biol Chem 2002; 277: 8730–8740.
- 17, , , . Sustained activation of p38 mitogen-activated protein kinase and JNK pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and TNFRI/TNF-alpha expression. Mol Cell Biol 2004; 24: 10352–10365.
- 18, , . Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinases activation mediating p53 apoptosis. J Biol Chem 2008; 283: 25455–25467.
- 19, , , , , . Hepatitis B virus X protein increases the Cdt1 to geminin ratio inducing DNA re-replication and polyploidy. J Biol Chem 2008; 283: 28729–287240.
- 20, , , , , , et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002; 13: 1929–1939.
- 21, , . Polo-like kinases and oncogenesis. Oncogene 2005; 24: 267–276.
- 22, , , . Polo-like kinases (Plks) and cancer. Oncogene 2005; 24: 287–291.
- 23, , , , , , et al. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun 1997; 234: 397–405.
- 24, , , , , . Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1. J Natl Cancer Inst 2004; 96: 862–872.
- 25, , , . Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines. J Biol Chem 1999; 274: 2327–2336.
- 26, , , , , , et al. Hepatic stem-like phenotype and interplay of Wnt/β-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 2008; 14: 471–484.
- 27, , , , , , et al. Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J Biol Chem 2007; 282: 11197–11204.
- 28, . Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos. HEPATOLOGY 2002; 36: 794–804.
- 29. Liver regeneration. J Cell Phys 2007; 213: 286–300.
- 30, , , , , , et al. Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma. Am J Clin Pathol 2005; 124: 31–36.
- 31, . Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997; 386: 761–763.
- 32, , , , , , et al. Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation. J Biol Chem 2004; 279: 30195–30201.
- 33, . Histone H2AX is phosphorylated in an ATR-dependent manner in response to replication stress. J Biol Chem 2001; 276: 47759–47762.
- 34, . The impact of negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 2007; 7: 861–869.
- 35, , , , , . BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000; 14: 927–939.
- 36, , . Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell 2004; 15: 799–811.
- 37, . Getting in and out of mitosis with Polo-like kinase-1. Oncogene 2005; 24: 2844–2859.
- 38, . The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat Cell Biol 2005; 7: 93–98.
- 39, , , . Mad2-independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev Cell 2001; 1: 227–237.
- 40, , , , , , et al, Dual roles of human bubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 2003; 4: 483–497.
- 41, , , , . Probing cell-division phenotype space and Polo-like kinases function using small molecules. Nat Chem Biol 2006; 2: 618–626.
- 42, , . Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007; 17: 157–162.
- 43, , , , , , et al. BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol 2007; 17: 316–322.
- 44, , , , , , et al. MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species. Cancer Res 2006; 66: 6598–6605.
- 45, , , , , , et al. Transcriptional regulation and function during the human cell cycle. Nat Genet 2001; 27: 48–54.
- 46, . Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339–346.
- 47, , , , , , et al. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation. Cancer Res 2007; 67: 7155–7164.